At a glance
- Originator Pfizer
- Class Azepines; Oligopeptides; Vasodilators
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 23 Feb 2001 Profile reviewed but no significant changes made
- 23 Sep 1997 No-Development-Reported for Hypertension in United Kingdom (Unknown route)
- 24 Oct 1994 Preclinical development for Hypertension in United Kingdom (Unknown route)